Automated latex photometric immunoassay for total plasminogen activator inhibitor-1 in plasma

Clinical Chemistry

Volumn 49, Issue 6, 2003, Pages 987-989

  Ono, Tomoko ^a   Sogabe, Maki ^a   Ogura, Minoru ^a   Furusaki, Fumio ^b  

^a Mitsubishi Kagaku Medical Inc   (Japan)

^b Management Department   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ANALYTIC METHOD; ARTICLE; AUTOMATION; BLOOD LEVEL; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOASSAY; MALE; PHOTOMETRY; REPRODUCIBILITY;

ADULT; AUTOANALYSIS; FEMALE; HUMANS; IMMUNOASSAY; LATEX; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOTOMETRY; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYSTYRENES; REFERENCE VALUES;

EID: 0037683330     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.6.987     Document Type: Article

References (13)

1. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombosis resistance. Circulation 1999;99:3050-5.
2. Handt S, Jerome WG, Tietze J, Hantgan PR. Plasminogen activator inhibitor-1 secretion by endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: evidence for a key role of endothelial cells in thrombolytic resistance. Blood 1996;87:4204-13.
3. Chandler WL, Loo SC, Nguyen SV, Schmer G, Stratton JR. Standardization of methods for measuring plasminogen activator inhibitor activity in human plasma. Clin Chem 1989;35:787-93.
4. Korninger C, Collen D. Neutralization of human extrinsic (tissue type) plasminogen activator in human plasma. No evidence for a specific inhibitor. Thromb Haemost 1981;46:662-5.
5. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator-1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988;71:220-5.
6. MacGregor IR, Booth NA. An enzyme-linked immunosorbent assay (LISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thromb Haemost 1988;59:68-72.
7. Nieuwenhuizen W, Laterveer R, Hoegee-de Nobel E, Bos R. A one-step enzyme immunoassay for total plasminogen activator inhibitor-1 antigen in human plasma. Blood Coagul Fibrinolysis 1995;6:268-72.
8. Vleugles N, Leys J, Knockaert I, Declerck PJ. Effect of stabilizing interaction on plasminogen activator inhibitor-1. Thromb Haemost 2000;84:871-5.
9. Huber K, Gunter C, Wojta J, Gulba D. Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Thromb Res 2001;103:S7-19.
10. Fukao H, Ueshoma S, Okada K, Yamamoto K, Matsuo T, Matsuo O. Tissue type plasminogen activator inhibitor, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Thromb Res 1992;68:57-65.
11. Saitou M, Nakabayashi T, Iuchi K, Ishikawa T, Kaseno K, Yoshida T. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic ahd fibrinolytic factors. Blood Coagul Fibrinolysis 1993;4:801-4.
12. Margaglione M, Cappucci G, d'Addedda M, Colaizzo D, Giuliani N, Vecchione G, et al. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol 1998;18:562-7.
13. Hekman C, Loskutoff DJ. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. Arch Biochem Biophys 1988;262:199-210.